Home › Funds › BAKER BROS. ADVISORS LP › IDYA

BAKER BROS. ADVISORS LP position in IDYA

IDEAYA BIOSCIENCES INC · Health Care

BAKER BROS. ADVISORS LP reported holding 5,010,030 shares of IDYA (IDEAYA BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$186.7M, representing 0.98% of its reported portfolio and ranking #16 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed IDYA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.01M sh
Reported value held$186.72M
Portfolio Weight0.98%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's IDYA position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in IDYA in Q3 2023 at 1,062,123 shares (US$28.7M). The position peaked in Q2 2026 at 5,010,030 shares, worth US$186.7M. Across 12 filings, BAKER BROS. ADVISORS LP increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 5,010,030 shares valued at US$186.7M — an increase of 1,063,515 shares quarter over quarter.. Notable position changes include a 99% increase in Q2 2025 (shares rose 29% over the following quarter), a 55% increase in Q3 2025 (shares rose 27% over the following quarter), a 27% increase in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.06M $28.66M New
Q4 2023 1.06M $37.79M Hold
Q1 2024 1.06M $46.61M Hold
Q2 2024 1.06M $37.29M Hold
Q3 2024 1.06M $33.65M Hold
Q4 2024 1.06M $27.30M Hold
Q1 2025 1.06M $17.40M Hold
Q2 2025 2.12M $44.54M Add
Q3 2025 3.28M $89.12M Add
Q4 2025 3.62M $125.10M Add
Q1 2026 3.95M $131.50M Add
Q2 2026 5.01M $186.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IDYA and 13F data

IDYA (IDEAYA BIOSCIENCES INC) is a Health Care company. 38 other funds we track also report a position in IDYA — the largest reported positions include Logos Global Management LP (US$111.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$101.2M), GSK plc (US$49.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IDYA

All IDYA fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held IDYA?

BAKER BROS. ADVISORS LP has disclosed IDYA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BAKER BROS. ADVISORS LP's current position in IDYA?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 5.01M shares of IDYA (IDEAYA BIOSCIENCES INC), valued at $186.72M, representing 0.98% of its reported portfolio and ranking #16.

Has BAKER BROS. ADVISORS LP been buying or selling IDYA?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP increased its position in IDYA. The position peaked in Q2 2026 at 5.01M shares.

Which other funds hold IDYA?

Other major institutional holders of IDYA include Logos Global Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., GSK plc, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.